Related Articles
FOXL1 overexpression is associated with poor outcome in patients with glioma
P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas
Six1 expression is associated with a poor prognosis in patients with glioma
The impact of high co-expression of Sp1 and HIF1α on prognosis of patients with hepatocellular cancer
High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma